Skip to main content
Premium Trial:

Request an Annual Quote

Amersham's MegaBace to Assist Brazil's Cancer Fight


SÃO PAULO--Amersham Pharmacia Biotech's high-throughput DNA sequencing system, MegaBace 1000, was picked recently by the Ludwig Institute for Cancer Research and the State of São Paolo Research Foundation to speed up efforts here to discover cancer-causing genes. The first of its kind in South America, the $10 million project is being funded equally by the research foundation and by the São Paulo branch of the Ludwig Institute, which is based in San Diego.

The project will cover six new Brazilian sequencing centers, including the Ludwig Institute, each of which will use a MegaBace 1000 as part of the endeavor to decode approximately 500,000 sequences of DNA by February 2001.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.